Conditional probability of long-term survival after resection of hilar cholangiocarcinoma

被引:40
|
作者
Buettner, Stefan [1 ]
Margonis, Georgios A. [1 ]
Kim, Yuhree [1 ]
Gani, Faiz [1 ]
Ethun, Cecilia G. [2 ]
Poultsides, George [3 ]
Thuy Tran [3 ]
Idrees, Kamran [4 ]
Isom, Chelsea A. [4 ]
Fields, Ryan C. [5 ]
Krasnick, Bradley [5 ]
Weber, Sharon M. [6 ]
Salem, Ahmed [6 ]
Martin, Robert C. G. [7 ]
Scoggins, Charles R. [7 ]
Shen, Perry [8 ]
Mogal, Harveshp D. [8 ]
Schmidt, Carl [9 ]
Beal, Eliza [9 ]
Hatzaras, Loannis [10 ]
Shenoy, Rivfka [10 ]
Maithel, Shishir K. [2 ]
Pawlik, Timothy M. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA
[2] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
[3] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[4] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA
[5] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[6] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
[7] Univ Louisville, Dept Surg, Louisville, KY 40292 USA
[8] Wake Forest Univ, Dept Surg, Winston Salem, NC 27109 USA
[9] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[10] NYU, Dept Surg, New York, NY 10016 USA
关键词
DISEASE-FREE SURVIVAL; PERIHILAR CHOLANGIOCARCINOMA; MULTIINSTITUTIONAL ANALYSIS; SURGICAL RESECTION; HEPATIC RESECTION; STAGING SYSTEM; CANCER; LIVER; MALIGNANCIES; CARCINOMA;
D O I
10.1016/j.hpb.2016.04.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: While traditional survival analyses focus on factors determined at the time of surgery, conditional survival (CS) estimates prognosis relative to time following treatment. We sought to compare actuarial and CS among patients undergoing curative intent surgery for hilar cholangiocarcinoma. Methods: 242 patients undergoing surgery between 2000 and 2014 were identified using a multi institutional database. CS was calculated as the probability of surviving an additional 3 years, given that the patient had already survived "x" years from surgery. Results: Median patient age was 67 years (IQR: 57-73) and most patients were male (n = 140, 57.9%). Lymph node metastases were noted in 79 (32.6%) patients while an RO margin was obtained in 66.1% (n = 160). Median OS was 22.3 months. Actuarial survival decreased over time from 46.3% at 2 years following surgery to 18.2% at 5 years; in contrast, the 3-year CS (CS3) increased with time (CS3 at 2 years was 39.3% versus 54.4% at 5 years). CS3 exceeded actuarial survival for high-risk patients with patients with perineural invasion demonstrating an actuarial survival of 15.4% at 5 years versus CS3 of 37.6% at 2 years following surgery (Delta = 22.2%). Conclusions: CS provides a more accurate, dynamic estimate for survival, especially among high-risk patients.
引用
收藏
页码:510 / 517
页数:8
相关论文
共 50 条
  • [31] Long-term Survival after resection for perihilar cholangiocarcinoma: Impact of UICC staging and surgical procedure
    Juntermanns, Benjamin
    Kaiser, Gernot Maximillian
    Reis, Henning
    Gries, Silvia
    Kasper, Stefan
    Paul, Andreas
    Canbay, Ali
    Fingas, Christian Dominik
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (05): : 454 - 460
  • [32] Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma
    Jarnagin, WR
    Bowne, W
    Klimstra, DS
    Ben-Porat, L
    Roggin, K
    Cymes, K
    Fong, YM
    DeMatteo, RP
    D'Angelica, M
    Koea, J
    Blumgart, LH
    ANNALS OF SURGERY, 2005, 241 (05) : 703 - 714
  • [33] Results after resection of hilar cholangiocarcinoma
    Tsao, J
    Braasch, J
    Dugan, J
    Martin, H
    HAMBURG '97 - EUROPEAN I.H.P.B.A. CONGRESS, 1997, : 515 - 517
  • [34] Extended Bile Duct Resection Liver and Transplantation in Patients with Hilar Cholangiocarcinoma: Long-Term Results
    Seehofer, Daniel
    Thelen, Armin
    Neumann, Ulf P.
    Veltzke-Schlieker, Winfried
    Denecke, Timm
    Kamphues, Carsten
    Pratschke, Johann
    Jonas, Sven
    Neuhaus, Peter
    LIVER TRANSPLANTATION, 2009, 15 (11) : 1499 - 1507
  • [35] Regarding: Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma
    Schmelzle, Moritz
    Sucher, Robert
    Seehofer, Daniel
    Pratschke, Johann
    SURGERY, 2016, 159 (03) : 986 - 987
  • [36] Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome
    Dumitrascu, Traian
    Chirita, Dragos
    Ionescu, Mihnea
    Popescu, Irinel
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (05) : 913 - 924
  • [37] Reply to: "Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma"
    Hoffmann, Katrin
    Schemmer, Peter
    Buechler, Markus W.
    SURGERY, 2016, 159 (03) : 987 - 988
  • [38] Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma
    Zhang, Xu-Feng
    Bagante, Fabio
    Chen, Qinyu
    Beal, Eliza W.
    Lv, Yi
    Weiss, Matthew
    Popescu, Irinel
    Marques, Hugo P.
    Aldrighetti, Luca
    Maithel, Shishir K.
    Pulitano, Carlo
    Bauer, Todd W.
    Shen, Feng
    Poultsides, George A.
    Soubrane, Olivier
    Martel, Guillaume
    Koerkamp, B. Groot
    Guglielmi, Alfredo
    Itaru, Endo
    Pawlik, Timothy M.
    SURGERY, 2018, 163 (05) : 1114 - 1120
  • [39] Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome
    Traian Dumitrascu
    Dragos Chirita
    Mihnea Ionescu
    Irinel Popescu
    Journal of Gastrointestinal Surgery, 2013, 17 : 913 - 924
  • [40] Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis
    Asakura, H
    Ohtsuka, M
    Ito, H
    Kimura, F
    Ambiru, S
    Shimizu, H
    Togawa, A
    Yoshidome, H
    Kato, A
    Miyazaki, M
    HEPATO-GASTROENTEROLOGY, 2005, 52 (63) : 722 - 724